Rohto Eye Drop Eye Injury Lawsuit Lawyers

FDA Class II Recall Raises Questions About Product Safety, Potential Eye Infections, and the Legal Rights of Consumers Who Suffered Injuries

What Parker Waichman LLP Found

• Nearly 12 million bottles of Rohto Cooling Eye Drops were recalled nationwide because sterility could not be assured.
• The FDA classified the action as a Class II recall, recognizing the potential for medically reversible injuries.
• Eye drops are required to be sterile because contamination can cause infections, inflammation, and vision-related injuries.
• Consumers who suffered eye injuries after using recalled products may have legal rights under product liability laws.
• Preserving the recalled bottle and obtaining prompt medical treatment may help support a future legal claim.

Millions of consumers rely on over-the-counter eye drops every day to relieve dry eyes, redness, irritation, digital eye strain, and discomfort caused by allergies or environmental conditions. Because these products come into direct contact with one of the body’s most sensitive tissues, consumers reasonably expect that every bottle has been manufactured under strict quality controls and is completely sterile. When questions arise about whether an eye drop solution is free from harmful microorganisms, the potential consequences can become serious.

The U.S. Food and Drug Administration (FDA) recently announced that nearly 12 million bottles of Rohto Cooling Eye Drops have been voluntarily recalled because there is a lack of assurance that the products are sterile. The recall affects products distributed throughout the United States and includes multiple Rohto eye drop formulations sold in both single and twin-pack configurations.

According to the FDA, approximately 11,960,623 cartons are included in this nationwide recall. Although federal regulators classified the action as a Class II recall, meaning serious adverse health consequences are not expected in most cases, contamination or loss of sterility involving ophthalmic products remains a significant public health concern because the eyes are highly susceptible to infection.

Consumers who have purchased these products are encouraged to determine whether their eye drops are included in the recall and stop using affected products immediately. Individuals who develop eye pain, redness, blurred vision, discharge, swelling, or signs of infection after using recalled eye drops should promptly seek medical evaluation.

Why Sterility Is Critical for Eye Drops

Unlike many other over-the-counter products, eye drops are intended to be placed directly onto the surface of the eye. The eye has delicate tissues that can become infected if exposed to bacteria, fungi, mold, or other microorganisms.

Sterility means that a product has been manufactured and packaged so that it contains no viable microorganisms capable of causing infection. Manufacturers of ophthalmic products must follow strict production standards designed to maintain sterile conditions from manufacturing through packaging.

When there is a “lack of assurance of sterility,” regulators cannot confirm that every bottle remains free of contamination. Even if contamination has not been identified in every unit, uncertainty about sterility creates unacceptable risks because consumers have no way of knowing whether the bottle they purchased is safe.

Contaminated eye drops may introduce microorganisms directly into the eye. Because tears, contact lenses, small scratches, previous eye surgery, and weakened immune systems can increase susceptibility to infection, even relatively small amounts of contamination may result in significant medical complications for certain individuals.

Understanding the FDA’s Class II Recall Classification

The FDA categorized this action as a Class II recall. This classification indicates that using the affected product may cause temporary or medically reversible health effects, or that the likelihood of serious injury is considered relatively low.

A Class II recall does not mean a product is safe. Instead, it reflects the FDA’s assessment of the expected severity of potential injuries based on available information.

Consumers should never ignore a recall simply because it is not classified as Class I. Ophthalmic products require exceptionally high manufacturing standards because any contamination reaches sensitive eye tissues almost immediately after application.

The FDA’s decision to recall nearly 12 million bottles demonstrates the seriousness of manufacturing concerns involving sterile eye care products.

Which Rohto Eye Drops Are Included in the Recall?

The recall includes eight Rohto Cooling Eye Drops products manufactured by Rohto-Mentholatum in Vietnam and distributed in the United States by The Mentholatum Company.

Affected products include:

• Rohto ALL-IN-ONE Cooling Eye Drops
• Rohto Max Strength Cooling Eye Drops
• Rohto Optic Glow
• Rohto Digi Eye
• Rohto Dry Aid
• Rohto Cool Relief
• Single-pack products
• Twin-pack products

The recalled products carry expiration dates ranging from July 2025 through February 2029.

Consumers should compare the lot number and expiration date printed on their packaging with the manufacturer’s recall information or the FDA’s published recall notice.

Potential Health Risks Associated With Non-Sterile Eye Drops

The eye contains delicate tissues that can be permanently damaged by infection or inflammation.

If microorganisms are introduced through contaminated eye drops, consumers may experience symptoms including:

• Eye redness
• Eye pain
• Burning sensations
• Blurred vision
• Excessive tearing
• Swelling
• Eye discharge
• Increased light sensitivity
• Corneal infections
• Vision impairment

Individuals with weakened immune systems, diabetes, recent eye surgery, glaucoma, chronic dry eye disease, or contact lens use may face greater risks of developing complications following exposure to contaminated ophthalmic products.

Although many infections can be successfully treated when diagnosed early, delayed treatment may increase the likelihood of permanent injury or vision loss.

Why Manufacturing Quality Control Matters

Manufacturers of sterile medical products must maintain extensive quality assurance procedures throughout production.

These safeguards often include:

• Sterile manufacturing environments
• Equipment validation
• Environmental monitoring
• Container integrity testing
• Sterility testing
• Batch documentation
• Ongoing quality inspections

When questions arise regarding sterility assurance, manufacturers may initiate voluntary recalls before widespread injuries occur. These recalls help prevent additional consumers from being exposed to potentially unsafe products.

Quality control failures involving sterile pharmaceuticals frequently become the subject of extensive regulatory investigations to determine whether manufacturing procedures complied with federal standards.

Product Liability Claims Involving Contaminated Eye Drops

Consumers who suffer injuries after using contaminated or defective eye care products may have legal rights under state product liability laws.

Depending on the circumstances, claims may involve allegations such as:

• Defective manufacturing
• Failure to maintain sterile production
• Negligent quality control
• Failure to warn consumers
• Product contamination
• Negligence
• Breach of warranty

Each case depends upon the specific facts surrounding the injury, including medical records, product identification, laboratory testing, recall documentation, and expert evaluation of the manufacturing process.

Individuals experiencing permanent vision damage, severe infections, hospitalization, or other significant injuries may incur substantial medical expenses, lost income, and long-term treatment costs.

Consumers Should Stop Using Recalled Products Immediately

The FDA advises consumers to stop using recalled Rohto eye drops immediately if their product is included in the recall.

Consumers should:

• Verify whether their product matches the recalled lot numbers and expiration dates.
• Stop using affected eye drops immediately.
• Return the product to the retailer or dispose of it according to recall instructions.
• Monitor for symptoms of eye irritation or infection.
• Seek prompt medical attention if symptoms develop.
• Preserve the recalled product if an injury has occurred, as it may become important evidence during an investigation.

Anyone experiencing worsening eye pain, changes in vision, or signs of infection should not delay seeking medical treatment.

Recent Eye Medication Recalls Highlight Ongoing Safety Concerns

The Rohto recall is not an isolated event.

The FDA has recently announced additional recalls involving ophthalmic medications, including more than 2.5 million bottles of prescription prednisolone acetate ophthalmic suspension after concerns involving foreign material were identified.

Multiple recalls involving sterile eye medications within a relatively short period highlight the importance of manufacturing quality, contamination prevention, and regulatory oversight.

Consumers should remain attentive to FDA safety announcements involving medications that come into direct contact with the eyes.

Rohto Eye Drop Injury Lawsuit FAQs

Can I file a lawsuit if I developed an eye infection after using recalled Rohto eye drops?

Possibly. A recall alone does not automatically create a lawsuit, but if you suffered an eye infection, vision problems, or another medically documented injury after using one of the recalled products, you may have grounds to pursue a product liability claim. An attorney can investigate whether your injuries may be linked to the recalled eye drops and determine which parties may be legally responsible.

What types of injuries could qualify for compensation?

Compensation depends on the facts of each case. Individuals who suffered eye infections, corneal injuries, vision impairment, hospitalization, ongoing treatment, or permanent vision loss may be able to seek damages for medical expenses, lost wages, future medical care, pain and suffering, diminished quality of life, and other legally recoverable losses.

What if I already threw away the recalled eye drops?

You may still have a claim. Medical records, pharmacy receipts, retailer purchase histories, photographs, and other documentation may help establish which product you purchased. If you still have the packaging or a receipt, keep those materials. An attorney can help determine what evidence is available even if the bottle has already been discarded.

Does a voluntary recall mean the manufacturer admitted fault?

No. Companies often initiate voluntary recalls to address potential safety concerns before regulators require additional action. A voluntary recall is not necessarily an admission of legal liability. However, recall information may become important evidence during a product liability investigation when combined with medical records, testing results, manufacturing documents, and other evidence.

How long do I have to file a lawsuit?

The deadline varies depending on the state where the injury occurred and other legal factors. Product liability claims are governed by statutes of limitations that differ across the country. Waiting too long may prevent an injured consumer from recovering compensation, so individuals who believe they were harmed should speak with an attorney as soon as reasonably possible.

Contact Parker Waichman LLP For A Free Case Review

Consumers purchase eye drops with the expectation that they are manufactured under strict sterile conditions. When questions arise about contamination or sterility, the consequences can include painful eye infections, vision problems, expensive medical treatment, and lasting complications. If you or a loved one suffered an eye injury after using recalled Rohto eye drops, you may have important legal rights.

Parker Waichman LLP represents individuals and families nationwide in product liability litigation involving defective consumer products and dangerous medications. The firm offers free consultations.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today to discuss your potential claim and learn whether you may be entitled to compensation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.